TrialClinical pharmacokinetics2022

Finerenone Dose-Exposure-Response for the Primary Kidney Outcome in FIDELIO-DKD Phase III: Population Pharmacokinetic and Time-to-Event Analysis.

Paul van den Berg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.